Tag Archives: Morcellators

FDA Issues Final Guidance On Morcellators Linked To Deadly Cancer Risk

December 30, 2020 By: Irvin Jackson
FDA Issues New Guidelines, Safety Communication On Use Of Power Morcellators

February 26, 2020 By: Russell Maas
Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study

September 30, 2019 By: Irvin Jackson
CDC Weighs New Guidelines For Gynecologists For Detecting Uterine Cancer

May 11, 2018 By: Irvin Jackson
Uterine Fibroid Drug Esmya May Be Linked To Liver Damage, EU Regulators Warn

February 14, 2018 By: Irvin Jackson
Top Drug Risks and Warnings Highlighted in 2017

December 26, 2017 By: Irvin Jackson
Power Morcellator Uterine Cancer Risks Raised In FDA Review

December 18, 2017 By: Irvin Jackson
Power Morcellator Cancer Problems Highlight FDA Post Marketing Surveillance Failures: JAMA Editorial

July 03, 2017 By: Irvin Jackson
Embolization May Be Effective Alternative Over Morcellation For Uterine Fibroid Removal

March 15, 2017 By: Irvin Jackson
Morcellator Cancer Deaths, Duodenoscope Infection Risks Spur FDA Meeting On Hospitals Reporting Medical Device Problems

December 05, 2016 By: Irvin Jackson

Ozempic NAION Vision Loss Risks Confirmed in Another Study (Posted 2 days ago)

A Danish study warns that using Ozempic and Wegovy could double the risk of a condition known to cause vision changes and blindness.

Lawsuit Alleges Depo-Provera Caused Brain Tumor, Spinal Cyst Requiring Constant Medical Monitoring (Posted 5 days ago)

The birth control injection Depo-Provera caused the development of brain tumors after just two years of receiving the injections, according to a recently filed product liability lawsuit.

BioZorb Marker Lawsuits Involving 100 Different Plaintiffs Pending in District of Massachusetts (Posted 6 days ago)

Lawsuits allege that recalled BioZorb Markers failed to absorb into the body after breast cancer treatments, resulting in painful complications and the need for additional medical procedures.

Tag Archives: Morcellators

FDA Issues Final Guidance On Morcellators Linked To Deadly Cancer Risk

FDA Issues New Guidelines, Safety Communication On Use Of Power Morcellators

Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study

CDC Weighs New Guidelines For Gynecologists For Detecting Uterine Cancer

Uterine Fibroid Drug Esmya May Be Linked To Liver Damage, EU Regulators Warn

Top Drug Risks and Warnings Highlighted in 2017

Power Morcellator Uterine Cancer Risks Raised In FDA Review

Power Morcellator Cancer Problems Highlight FDA Post Marketing Surveillance Failures: JAMA Editorial

Embolization May Be Effective Alternative Over Morcellation For Uterine Fibroid Removal

Morcellator Cancer Deaths, Duodenoscope Infection Risks Spur FDA Meeting On Hospitals Reporting Medical Device Problems

More Top Stories

Review A Case